Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center